View full ISI View full PI

Important Information

INDICATION & USAGE

INGREZZA (valbenazine) capsules is indicated for the treatment of adults with tardive dyskinesia.

Important Safety Information

WARNINGS & PRECAUTIONS

Somnolence

INGREZZA can cause somnolence. Patients should not perform activities requiring mental alertness such as operating a motor vehicle or operating hazardous machinery until they know how they will be affected by INGREZZA.

Important Information

Approved Use

INGREZZA (valbenazine) capsules is a prescription medicine used to treat adults with movements in the face, tongue, or other body parts that cannot be controlled (tardive dyskinesia).

It is not known if INGREZZA is safe and effective in children.

IMPORTANT SAFETY INFORMATION

INGREZZA may cause serious side effects, including:

  • Sleepiness (somnolence). Do not drive, operate heavy machinery, or do other dangerous activities until you know how INGREZZA affects you.

Introducing the INBRACE™ Support Program

The INBRACE Support Program offers support designed to help patients who are prescribed INGREZZA® (valbenazine) capsules.

From reimbursement verification and financial assistance to prescription fulfillment and product support, the program assists patients and their caregivers—so they can focus on treatment goals.

Our process starts with the INGREZZA Treatment Form, which both enrolls patients into the INBRACE Support Program and is their prescription for INGREZZA.

3 steps to prescribe INGREZZA and enroll your patients

Once the prescription is processed, a specialty pharmacy will call your patient to arrange next-day shipment of the INGREZZA prescription directly to your patient at a location of their choosing.

  • INGREZZA Savings Program

    Assists with patient copays. Eligible patients may qualify for a $0 copay on their INGREZZA prescription.* Terms & Conditions

    *This offer is only valid for patients who have commercial (nongovernment-funded) insurance.  Additional terms and conditions apply.

  • INGREZZA Start ProgramThe INGREZZA Start Program is a free one-time 37-day supply of INGREZZA for new patients. To obtain a free trial for your patient, complete the INGREZZA Start Program section on the INGREZZA Treatment Form.

  • This program is not contingent on a purchase of any kind. Product dispensed under this free trial program may not be submitted for reimbursement to any third-party payer. We reserve the right to modify or cancel the program at any time.

  • For patients without insurance coverage for INGREZZAEligible patients who are uninsured and lack the financial resources to pay for their medicine may be able to receive their prescription at no cost through the INGREZZA Patient Assistance Program.

Additional terms and conditions apply.

Introducing the INBRACE™ Support Program

The INBRACE Support Program offers support designed to help patients who are prescribed INGREZZA® (valbenazine) capsules.

The program offers a range of services, such as:

  • Information on financial assistance
  • Prescription delivery
  • Product support

Download the Patient Instructions for your guide to obtaining your INGREZZA treatment.

  • INGREZZA Savings Program

    Help with out‐of‐pocket costs. Eligible patients may qualify for a $0 copay on their INGREZZA prescription.* Terms & Conditions

    *This offer is only valid for patients who have commercial (nongovernment-funded) insurance.  Additional terms and conditions apply.

  • INGREZZA Start ProgramThe INGREZZA Start Program is a free one-time 37-day supply of INGREZZA for new patients. To obtain a free trial, your physician will need to complete the INGREZZA Start Program section on the INGREZZA Treatment Form.

  • This program is not contingent on a purchase of any kind. Product dispensed under this free trial program may not be submitted for reimbursement to any third-party payer. We reserve the right to modify or cancel the program at any time.

  • For patients without insurance coverage for INGREZZAEligible patients who are uninsured and lack the financial resources to pay for their medicine may be able to receive their prescription at no cost through the INGREZZA Patient Assistance Program.

Additional terms and conditions apply.

Important Information

INDICATION & USAGE

INGREZZA (valbenazine) capsules is indicated for the treatment of adults with tardive dyskinesia.

Important Safety Information

WARNINGS & PRECAUTIONS

Somnolence

INGREZZA can cause somnolence. Patients should not perform activities requiring mental alertness such as operating a motor vehicle or operating hazardous machinery until they know how they will be affected by INGREZZA.

QT Prolongation

INGREZZA may prolong the QT interval, although the degree of QT prolongation is not clinically significant at concentrations expected with recommended dosing. INGREZZA should be avoided in patients with congenital long QT syndrome or with arrhythmias associated with a prolonged QT interval. For patients at increased risk of a prolonged QT interval, assess the QT interval before increasing the dosage.

ADVERSE REACTIONS

The most common adverse reaction (≥5% and twice the rate of placebo) is somnolence. Other adverse reactions (≥2% and >Placebo) include: anticholinergic effects, balance disorders/falls, headache, akathisia, vomiting, nausea, and arthralgia.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch at www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see INGREZZA full Prescribing Information or visit www.INGREZZA.com

Reference: INGREZZA [package insert]. San Diego, California: Neurocrine Biosciences, Inc.; 2017.

Important Information

Approved Use

INGREZZA (valbenazine) capsules is a prescription medicine used to treat adults with movements in the face, tongue, or other body parts that cannot be controlled (tardive dyskinesia).

It is not known if INGREZZA is safe and effective in children.

IMPORTANT SAFETY INFORMATION

INGREZZA may cause serious side effects, including:

  • Sleepiness (somnolence). Do not drive, operate heavy machinery, or do other dangerous activities until you know how INGREZZA affects you.
  • Heart rhythm problems (QT prolongation). INGREZZA may cause a heart problem known as QT prolongation.
    Symptoms of QT prolongation may include: fast, slow, or irregular heartbeat, shortness of breath, dizziness or fainting.

Tell your healthcare provider right away if you have a change in your heartbeat (a fast or irregular heartbeat), or if you faint.

Before taking INGREZZA, tell your healthcare provider about all of your medical conditions including if you: have liver or heart problems, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

The most common side effect of INGREZZA is sleepiness (somnolence). Other common side effects include changes in balance (balance problems, dizziness) or an increased risk of falls, headache, feelings of restlessness, dry mouth, constipation, and blurred vision.

These are not all of the possible side effects of INGREZZA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see INGREZZA full Prescribing Information or visit www.INGREZZA.com